Zerion Pharma | INTERVIEW | Investing in Life Science 2024

BioStock’s Natasha Bank interviews Ole Wiborg, CEO of Zerion Pharma, at Investing in Life Science – From Seed To Success.   

About the event
On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success.

The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who provide the funds.

From early-stage investments, where business angels and seed investors drive medical breakthroughs, to growth-stage investments empowering promising ventures to become ready for partnering and/or fueling market expansion and later-stage strategic investments accelerating growth and facilitating a global market presence.

The “Investing in life science: From seed to success” event catered to life science companies in all development stages, who gained insight from investors in the various life cycle stages, simultaneously providing investors a chance to pick the brains of peers, engage in thought-provoking discussions and meet life science companies in early-to-commercial stages.

Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn:   / biostock  
Facebook:   / biostock.se  

https://www.biostock.se/
#BioStock #LifeScience #ZerionPharma

About BioStock
BioStock is Scandinavia's leading digital news and analysis service, exclusively focusing on the Life Science sector. Our primary editorial office and tv-studio are found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies.